Lyell Immunopharma (LYEL) Earnings Date, Estimates & Call Transcripts → Urgent new message from Porter Stansberry (From Porter & Company) (Ad) Free LYEL Stock Alerts $2.08 -0.08 (-3.70%) (As of 03/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLYEL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LYEL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit Lyell Immunopharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.91) EPSNext Year EPS Consensus Estimate: ($0.93) EPSLYEL Earnings Date and InformationLyell Immunopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.Read More Get Lyell Immunopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for LYEL and its competitors with MarketBeat's FREE daily newsletter. Lyell Immunopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Estimated)------- 11/7/2023Q3 2023($0.27)($0.20)+$0.07($0.20)$2.50 million$0.03 million8/8/2023Q2 2023($0.30)($0.26)+$0.04($0.26)$3.31 million$0.03 million5/4/2023Q1 2023($0.28)($0.27)+$0.01($0.27)$2.50 million$0.07 million2/28/2023Q4 2022($0.31)($0.03)+$0.28($0.03)$2.85 million$48.39 million11/8/2022Q3 2022($0.34)($0.28)+$0.06($0.28)--8/4/2022Q2 2022($0.31)($0.15)+$0.16($0.15)$3.37 million$35.74 million Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 5/10/2022Q1 2022($0.27)($0.28)($0.01)($0.28)$2.66 million$0.55 million3/29/2022Q4 2021-($0.18)($0.18)($0.18)$2.64 million$2.82 million11/12/2021Q3 2021($0.27)($0.20)+$0.07($0.20)$2.42 million$2.76 million8/12/2021Q2 2021($1.54)($1.25)+$0.29($1.03)$2.42 million$2.63 million Lyell Immunopharma Earnings - Frequently Asked Questions When is Lyell Immunopharma's earnings date? Lyell Immunopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on LYEL's earnings history. How much revenue does Lyell Immunopharma generate each year? Lyell Immunopharma (NASDAQ:LYEL) has a recorded annual revenue of $130,000.00. How much profit does Lyell Immunopharma generate each year? Lyell Immunopharma (NASDAQ:LYEL) has a recorded net income of -$234.63 million. LYEL has generated -$0.93 earnings per share over the last four quarters. What is Lyell Immunopharma's EPS forecast for next year? Lyell Immunopharma's earnings are expected to decrease from ($0.91) per share to ($0.93) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RVNC Earnings Results BMEA Earnings Results ALEC Earnings Results LIAN Earnings Results MLYS Earnings Results IGMS Earnings Results ELVN Earnings Results ALT Earnings Results TVTX Earnings Results PAHC Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:LYEL) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.